-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Psoriasis is a complex immune-mediated inflammatory disease (IMID) associated with several important diseases, including arthritis, cardiometabolic disease, and mood disorders
.
The average age of onset of psoriasis is 33 years
We recognize the potential for early intervention in psoriasis to improve patient care and integrate service delivery
.
This led to the development of the Psoriasis Rapid Access Clinic (PRAC), an innovative consultant-led multidisciplinary clinic
The pilot clinic was fully operational for seven months before the outbreak of the Covid-19 pandemic
.
Fifty-three patients were reviewed, 39 of whom met the target characteristics
Although, to our knowledge, this is the world's first multidisciplinary early access clinic for the treatment of psoriasis; the benefits of early intervention are recognized for other IMIDs, such as rheumatoid arthritis and Crohn's disease, early Targeted treatment may alter the course of the disease
.
This has not been proven for psoriasis, but has been hypothesized
Early access to psoriasis diagnosis and treatment may prevent long-term sequelae as the disease is better controlled and coexisting conditions are screened for and treated
.
The PRAC model has the potential to save future medical and social resource costs
Source: Reid C, Welsh C, Martin-Smith H, A Rapid Access Clinic for Psoriasis - First Experiences.
leave a message here
